Answers are grounded in this paper and cite their sources.
A randomised double blind crossover trial of Bromocriptine against an inert placebo was performed in 14 patients with primary sensory urgency. Bromocriptine was found to have no therapeutic advantage for these patients and the possible explanations for this finding are discussed.
No takes yet. Share an insight, caveat, or question.
O'BOYLE et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: